Article
Salt Lake City, UT-Paradigm Medical announces that its optimism over news that prospects of the $70-million purchase order the company reported recently were not as solid as it had thought.
Case studies highlight advanced techniques in glaucoma management
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Researchers investigate how COVID-19 affects retinal microvascular structure
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
FDA approves continuous delivery ranibizumab injection (Susvimo) for the treatment of diabetic macular edema
Study investigates neurological impact of diabetic vitreous hemorrhage